Sarcoidosis induced by Tocilizumab: A paradoxical event?

Journal of Rheumatology

Volumn 40, Issue 10, 2013, Pages 1773-1774

  Nutz, Anaiz ^a   Pernet, Charlotte ^b   Combe, Bernard ^a   Cohen, Jean David ^a  

^a LAPEYRONIE HOSPITAL   (France)

^b GUI DE CHAULIAC HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CERTOLIZUMAB PEGOL; DIPEPTIDYL CARBOXYPEPTIDASE; ETANERCEPT; METHOTREXATE; PREDNISONE; SALAZOSULFAPYRIDINE; TOCILIZUMAB;

ADULT; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DAS28; DISEASE CLASSIFICATION; DISEASE DURATION; DISEASE EXACERBATION; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; DRUG WITHDRAWAL; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; GRANULOMA; HEALTH ASSESSMENT QUESTIONNAIRE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; JOINT SWELLING; LETTER; LUNG SARCOIDOSIS; LYMPHADENOPATHY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RHEUMATOID ARTHRITIS; SARCOIDOSIS; SKIN BIOPSY; SKIN NODULE; SYNOVITIS; TENOSYNOVITIS; WEIGHT REDUCTION;

ADULT; ANTIBODIES, MONOCLONAL, HUMANIZED; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; HUMANS; SARCOIDOSIS;

EID: 84885165753     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.130278     Document Type: Letter

References (10)

1. Joyau C, Veyrac G, Dixneuf V, Jolliet P. Anti-tumour necrosis factor alpha therapy and increased risk of de novo psoriasis: is it really a paradoxical side effect? Clin Exp Rheumatol 2012;30:700-6.
2. Williams VL, Cohen PR. TNF alpha antagonist-induced lupus-like syndrome: report and review of the literature with implications for treatment with alternative TNF alpha antagonists. Int J Dermatol 2011;50:619-25.
3. Ramos-Casals M, Britero-Zeron P, Cuadrado MJ, Khamashta MA. Vasculitis induced by tumor necrosis factor-targeted therapies. Curr Rheumatol Rep 2008;10:442-8.
4. Daïen CI, Monnier A, Claudepierre P, Constantin A, Eschard JP, Houvenagel E, et al. Sarcoid-like granulomatosis in patients treated with tumor necrosis factor blockers: 10 cases. Rheumatology 2008;48:883-6.
5. Urbankowski T, Hoser G, Domagala-Kulawik J. Th1/Th2/Th17 related cytokines in the bronchoalveolar lavage fluid of patients with sarcoidosis: association with smoking. Pol Arch Med Wewn 2012;122:320-5.
6. Ishioka S, Saito T, Hiyama K, Haruta Y, Maeda A, Hozawa S, et al. Increased expression of tumor necrosis factor-alpha, interleukin-6, platelet-derived growth factor-B and granulocyte-macrophage colony-stimulating factor mRNA in cells of bronchoalveolar lavage fluids from patients with sarcoidosis. Sarcoidosis Vasc Diffuse Lung Disease 1996;13:139-45.
7. Maniwa K, Ogushi F, Haku T, Sone S, Ohmoto Y. Sarcoidosis associated with acute renal failure and increased levels of interleukin-6 in urine. Intern Med 1998;37:757-61.
8. Wendling D, Dernis E, Prati C, Frisch E, Delbosc B. Onset of inflammatory eye disease under tocilizumab treatment for rheumatologic conditions: a paradoxical effect [letter]? J Rheumatol 2011;38:2284.
9. Wendling D, Letho-Gyselinck H, Guillot X, Prati C. Psoriasis onset with tocilizumab treatment for rheumatoid arthritis [letter]. J Rheumatol 2012;39:657.
10. Matsuo Y, Mizoguchi F, Kohsaka H, Ito E, Eishi Y, Miyasaka N. Tocilizumab-induced immune complex glomerulonephritis in a patient with rheumatoid arthritis. Rheumatology 2013 Jan 15. [E-pub ahead of print].